Friday, 26 April 2024
Capricor Therapeutics Inc.
NASDAQ : CAPR
5.830 14 Oct 22 00:00 | Change: 0.35 | Open: 6.110 | High: 6.240 | Ask: 0.000 | Volume: 240,800 |
Change(%): 5.66 | Prev: 6.180 | Low: 5.810 | Bid: 0.000 | Avg vol: 0 |
10:45 | 15/3/18
Smarter Analyst
Capricor Therapeutics Inc (NASDAQ:CAPR) reported its fourth quarter and full year 2017 financial results. It also provided a corporate update.
more»
03:48 | 14/3/18
Frisco Fastball
Granite Point Capital Mgmt Lp stated it has 0.02% of its portfolio in Capricor Therapeutics, Inc. (NASDAQ:CAPR). Northern Tru owns 17,087 shares for 0% of their portfolio.
more»
10:00 | 9/3/18
GlobeNewswire
LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other ...
more»
10:56 | 17/2/18
Simply Wall St
Linda Marbán is the CEO of Capricor Therapeutics Inc (NASDAQ:CAPR), which has recently grown to a market capitalization of US$51.42M.
more»
04:00 | 17/2/18
Stock Watch
At the moment, the 14-days ATR for Capricor Therapeutics, Inc. (NASDAQ: CAPR) is noted at 0.18. Disclaimer: Any news, report, research, and analysis published on Stocksnewstimes.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |